Medicare Archives

Healthcare Industry News Weekly Wrap-Up: February 16, 2024

// Biotech and Pharma Therapeutics Sage Touts Strong Launch for Postpartum Depression Drug Zurzuvae February 15, 2024 / Depression / Postpartum / Women’s Health / Sage Therapeutics Despite launching with just days left in 2023, Sage Therapeutics’ postpartum depression therapy...

February 16, 2024

Weekly Wrap-Up

Healthcare Industry News Weekly Wrap-Up: February 2, 2024

// Biotech and Pharma Therapeutics Endocrinology company Valendo Health launches with $4M and two provider partners January 31, 2024 / Endocrinology / Diabetes / Telehealth Valendo Health, a diabetes-focused, value-based endocrinology company, announced its launch with $4 million in seed...

February 2, 2024

Weekly Wrap-Up

Healthcare Industry News Weekly Wrap-Up: January 26, 2024

// Biotech and Pharma Therapeutics Lilly gene therapy finding puts focus on hearing loss treatment pipeline January 24, 2024 / Eli Lilly / Gene Therapy / Drug Target / Hearing loss An 11-year-old boy who was born deaf can hear...

January 26, 2024

Weekly Wrap-Up

Healthcare Industry News Weekly Wrap-Up: January 19, 2024

// Biotech and Pharma Therapeutics Kyverna sets plans for IPO in test of biotech enthusiasm January 17, 2024 / Kyverna / IPO / Startup More than two years after the bottom fell out for biotech stocks, the market for IPOs...

January 19, 2024

Weekly Wrap-Up

Healthcare Industry News Weekly Wrap-Up: January 12, 2024

// Biotech and Pharma Therapeutics CRISPR pioneer Doudna allies with Danaher for gene editing center targeting rare disease and beyond January 9, 2024 / Jennifer Doudna / CRISPR / Danaher / Gene Editing CRISPR pioneer Jennifer Doudna, Ph.D., looks set...

January 12, 2024

Weekly Wrap-Up

Healthcare Industry News Weekly Wrap-Up: December 22, 2023

// Biotech and Pharma Therapeutics Tome Biosciences debuts with $213M and a new way to edit the genome December 12, 2023 / Tome Biosciences / Gene Editing / DNA / Startup Biotechnology startup Tome Biosciences emerged from stealth on Tuesday...

December 22, 2023

Weekly Wrap-Up

Healthcare Industry News Weekly Wrap-Up: October 20, 2023

// Biotech and Pharma Therapeutics Bayer opens California plant to make cell therapies October 10, 2023 / Bayer / California / Cell Therapies / Parkinson’s The new facility is the latest investment from Bayer into cell and gene therapy. Bayer has...

October 20, 2023

Weekly Wrap-Up

Healthcare Industry News Weekly Wrap-Up: October 13, 2023

October 13, 2023

Weekly Wrap-Up

Healthcare Industry News Weekly Wrap-Up: October 6, 2023

// Biotech and Pharma Therapeutics Boehringer Ingelheim embraces dual-pricing tactic with launch of unbranded Humira biosimilar October 4, 2023 / Boehringer Ingelheim / Humira / AbbVie / Biosimilars After debuting its branded Humira biosim Cyltezo in July, Boehringer has launched...

October 6, 2023

Weekly Wrap-Up

Healthcare Industry News Weekly Wrap-Up: September 8, 2023

// Biotech and Pharma Therapeutics Roche’s Genentech bets on radiopharmaceuticals in partnership with PeptiDream September 20, 2023 / Roche / PeptiDream / Cancer / Bristol Myers Interest in radiopharmaceuticals has been taking off ever since Novartis won drug approval of...

September 8, 2023

1 2 3 4

Tag: Medicare

Healthcare Industry News Weekly Wrap-Up: February 16, 2024

Healthcare Industry News Weekly Wrap-Up: February 2, 2024

Healthcare Industry News Weekly Wrap-Up: January 26, 2024

Healthcare Industry News Weekly Wrap-Up: January 19, 2024

Healthcare Industry News Weekly Wrap-Up: January 12, 2024

Healthcare Industry News Weekly Wrap-Up: December 22, 2023

Healthcare Industry News Weekly Wrap-Up: October 20, 2023

Healthcare Industry News Weekly Wrap-Up: October 13, 2023

Healthcare Industry News Weekly Wrap-Up: October 6, 2023

Healthcare Industry News Weekly Wrap-Up: September 8, 2023

Contact Us

Vault Bioventures HQ

Maximize Innovation

Strategic Clarity

Strategy⁺

About Vault

Tag: Medicare

Contact Us

Vault Bioventures HQ

Maximize Innovation

Strategic Clarity

Strategy+

About Vault

Strategy⁺